Vycor Medical (VYCO) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.47% |
| Dec 31, 2025 | -3.39% |
| Sep 30, 2025 | -1.78% |
| Jun 30, 2025 | -2.76% |
| Mar 31, 2025 | -3.65% |
| Dec 31, 2024 | -1.78% |
| Sep 30, 2024 | -0.21% |
| Jun 30, 2024 | -2.45% |
| Mar 31, 2024 | -4.04% |
| Dec 31, 2023 | -1.01% |
| Sep 30, 2023 | -5.64% |
| Jun 30, 2023 | -6.54% |
| Mar 31, 2023 | -9.29% |
| Dec 31, 2022 | -9.91% |
| Sep 30, 2022 | -11.40% |
| Jun 30, 2022 | -12.97% |
| Mar 31, 2022 | -14.82% |
| Dec 31, 2021 | -8.83% |
| Sep 30, 2021 | -7.59% |
| Jun 30, 2021 | -8.75% |
| Mar 31, 2021 | -11.31% |
| Dec 31, 2020 | -14.95% |
| Mar 31, 2020 | -18.94% |
| Dec 31, 2019 | -25.53% |
| Sep 30, 2019 | -24.60% |
| Jun 30, 2019 | -25.11% |
| Mar 31, 2019 | -24.52% |
| Dec 31, 2018 | -13.17% |
| Sep 30, 2018 | -9.03% |
| Jun 30, 2018 | -10.41% |
| Mar 31, 2018 | -10.17% |
| Dec 31, 2017 | -10.76% |
| Sep 30, 2017 | -8.36% |
| Jun 30, 2017 | -7.72% |
| Mar 31, 2017 | -9.43% |
| Dec 31, 2016 | -16.10% |
| Sep 30, 2016 | -18.92% |
| Jun 30, 2016 | -18.78% |
| Dec 31, 2015 | 0.58% |